Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Vancomycin Resistant Enterococci Infection: early-phase trial registry
2 of 2 indexed Vancomycin Resistant Enterococci Infection trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Vancomycin Resistant Enterococci Infection: 2 US clinical trials tracked, 2 recruiting.
Vancomycin Resistant Enterococci Infection is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Riverside University Health System Medical Center, running 1 of these trials.
Enrollment posture brief
Registry condition vancomycin-resistant-enterococci-infection
OPEN 2 | RECR 100% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Vancomycin Resistant Enterococci Infection lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Vancomycin Resistant Enterococci Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Vancomycin Resistant Enterococci Infection is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
The Methodist Hospital Research Institute
NCT06258551
Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients
Riverside University Health System Medical Center
NCT07221370
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Vancomycin Resistant Enterococci Infection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Vancomycin Resistant Enterococci Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Vancomycin Resistant Enterococci Infection page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Vancomycin Resistant Enterococci Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Riverside University Health System Medical Center sponsors the most Vancomycin Resistant Enterococci Infection trials on record, review their full trial history before evaluating a specific study. See Riverside University Health System Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vancomycin Resistant Enterococci Infection condition card totals 2 registered trials; most-linked intervention Vancomycin 125mg; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.